BJOG An International Journal of Obstetrics & Gynaecology · 2003 · 92 citations · 26 references
Public HealthMaternal HealthObstetricsHigh-risk PregnancyMaternal-fetal MedicineReproductive ImmunologyEclampsiaIntrauterine Growth RestrictionMaternal EpidemiologyPlacental ImmunologyPregnancyPregnancy ImmunologyAntibodiesAtherosclerosis RiskInfections In PregnancyIntrauterine Fetal Growth RestrictionPre-eclampsia ImmunopathologyPreeclampsia Pathophysiology
OBJECTIVE: The origins of pre-eclampsia/eclampsia lie in a mismatch between feto-placental demands and utero-placental supply, a situation that also arises in normotensive intrauterine growth restriction (IUGR). Could reactivated chronic infection be both a trigger for these differential maternal responses to the same underlying pathology and a link between pre-eclampsia and its attendant lifelong risks of atherosclerosis? DESIGN: Nested case-control study. SETTING: Tertiary obstetric centre. POPULATION: Cases of pre-eclampsia, normotensive IUGR and controls. METHODS: A nested case-control study of serum from a population-based bank was performed. Seroprevalence and levels of anti-cytomegalovirus (CMV) and Chlamydophila pneumoniae immunoglobulin G (IgG) were compared (non-parametrically) between women with early onset pre-eclampsia (<34 weeks of gestation, n = 9), late onset pre-eclampsia (> or =34 + 0 weeks of gestation, n = 29), normotensive IUGR (birthweight less than third centile, n = 33) and matched normal pregnancy (n = 113, up to 2 per case). RESULTS: There was a significant difference in both anti-CMV and Chl. pneumoniae antibodies between groups (Kruskal-Wallis test, P < 0.05). Women with early onset pre-eclampsia had higher anti-CMV levels (median: 79, 95% confidence interval [95% CI] = 47, 164) than women with late onset pre-eclampsia (26 [95% CI = 22, 82], P < 0.05), normotensive IUGR (40 [95% CI = 31, 72], P < 0.05) and normal pregnancy (49 [95% CI = 45, 70], P < 0.05). Women with normotensive IUGR had significantly lower anti-Chl. pneumoniae antibodies (0.10 [95% CI = 0.08, 0.38]) than did normal pregnancy controls (0.21 [95% CI = 0.20, 0.28], P <0.05). CONCLUSIONS: The anti-CMV and anti-Chl. pneumoniae antibodies were higher in early onset pre-eclampsia than in late onset pre-eclampsia, normotensive IUGR and normal pregnancy. This may provide a pathophysiological link between pre-eclampsia and the known increased risk for subsequent atherosclerosis.
26
The National Institute for Clinical Excellence
Nursing Management · 2001 · 3.9K citations
Preeclampsia: An endothelial cell disorder
James Roberts, Robert N. Taylor, Thomas J. Musci et al. · American Journal of Obstetrics and Gynecology · 1989 · 1.9K citations
Medicine, Gynecology, Obstetrics +11
T. Yee Khong, Frank de Wolf, W.B. Robertson et al. · BJOG An International Journal of Obstetrics & Gynaecology · 1986 · 1.6K citations
Life Sciences, Anatomy, Obstetrics +17